跳到正文
研踪PaperTrail

论文库

检索计算机领域论文,按研究方向、作者或关键词筛选。

部分采集异常
正在读取账号与研究记录…

全站更新概况

+1171新增论文
+938其中 AI 相关
+130已有论文修订
+94新增 AI 导读

arXiv 最近完成扫描:2026-11-19 06:59 · 全站最近入库:2026-11-19 17:46各信源进度 →

统计口径与数据新鲜度

统计 2026-11-18 17:55 — 2026-11-19 17:55(北京时间) · 点击数字查看对应简报;AI 相关包含在新增论文内。

最近完成检查:2026-11-19 06:59最近发现新增版本:2026-11-19 17:46库内论文最新更新时间:2026-11-19 02:59

每分钟刷新已保存的数据。空检查不代表采集异常;新收录可能包含历史论文。AI 导读按新增版本计数。

27,410 已收录论文22,788 AI 相关8,343 有修订112 HF 社区发现

浏览论文库

时间范围跟随排序:版本更新、本站收录或首次发表。最新收录可能包含历史论文。部分信源异常,查看状态 →

找到 2 篇论文 · 按版本更新时间排序上轮扫描起点 2026-11-19 06:57(北京时间)
新论文 · v1arXiv:2611.19339

From Mutation to Medication: Characterizing Failures of Clinical LLMs to Respect Genomic Resistance

Negin Ashrafi, Roxana Daneshjou

原文摘要

Language models are increasingly proposed to support molecular tumour boards, but may recommend cancer therapies despite genomic evidence of resistance. We evaluated ten models on 1,464 resistance cases from five curated oncology knowledge bases, collecting 58,910 judgments. Models endorsed resisted therapies in 21.8-81.4% of cases. However, raw rates can reflect a tendency to agree rather than an ability to distinguish resistance from drug sensitivity: one open-weight model endorsed 81.4% of resistance cases and 82.3% of sensitivity controls. We therefore compared endorsement within matched gene and evidence-level groups. This analysis is exploratory because it was specified after the pre-registered analysis, which yielded null-to-weak results. Measured failures depended strongly on the reference knowledge base and evidence strength. When a second source independently confirmed resistance, four models across three vendors endorsed at most 2.4% of cases; at weaker evidence tiers, discrimination was not measurable. Models sometimes acknowledged resistance yet recommended the therapy. Repeating a model's own resistance conclusion reduced endorsement to 0.0-3.5% on cases where it had stated resistance. Falsely attributing the opposite conclusion increased endorsement above baseline for all seven hosted models, reaching 95.2% for GPT-4o; an instruction without an attributed conclusion changed endorsement by only 0.9 percentage points. Providing the correct curated evidence reduced unqualified strong recommendations to 0.3-3.5%, testing evidence use under an oracle condition rather than retrieval.

cs.AI · cs.LG · q-bio.GN

版本更新 · v2arXiv:2611.11051

PRISM: Preference-based Reward and Uncertainty-Integrated Synthesis Minimization for RTL PPA Optimization

Armin Abdollahi, Negin Ashrafi, Mehdi Kamal, Massoud Pedram

原文摘要

This paper introduces a budget-aware, multi-objective framework (called PRISM) for RTL optimization that improves power, performance, and area (PPA) while sharply limiting expensive commercial synthesis tool calls. Starting from a synthesizable baseline and functional testbench, the method iterates through LLM-driven rewrite generation, fast compile/simulation equivalence filtering, low-cost proxy feature extraction, and selective commercial synthesis tool (Synopsys Design Compiler (DC)) evaluation. To prioritize which candidates deserve high-quality synthesis, we train a preference-based reward model using pairwise ranking supervision derived from commercial synthesis tool outcomes, and combine ensemble uncertainty with a diversity-aware acquisition rule to avoid early bias and redundant evaluations. A key advantage is that PRISM maintains a best-tradeoff set G of non-dominated designs throughout the run: G preserves the best solutions found so far, is fed back into generation and refinement, and enables consistent, cumulative improvements rather than repeatedly restarting from the baseline. Across RTLLM v2.0 modules, the approach consistently yields post-synthesis gains under fixed commercial synthesis tool call budgets, and ablations confirm that reward-guided selection and candidate dropping are central to sample-efficient progress. PRISM efficacy is evaluated across multiple technology nodes (7 nm, 15 nm, and 45 nm) using identical pipelines without retraining.

cs.AR · cs.SE